- Home
- ARW vs AXSM Comparison
ARW vs AXSM Comparison
Compare ARW & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARW
- AXSM
- Stock Information
- Founded
- ARW 1935
- AXSM 2012
- Country
- ARW United States
- AXSM United States
- Employees
- ARW N/A
- AXSM N/A
- Industry
- ARW Electronic Components
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ARW Technology
- AXSM Health Care
- Exchange
- ARW Nasdaq
- AXSM Nasdaq
- Market Cap
- ARW 5.3B
- AXSM 5.1B
- IPO Year
- ARW N/A
- AXSM 2015
- Fundamental
- Price
- ARW $117.96
- AXSM $107.76
- Analyst Decision
- ARW Hold
- AXSM Strong Buy
- Analyst Count
- ARW 4
- AXSM 15
- Target Price
- ARW $121.25
- AXSM $170.20
- AVG Volume (30 Days)
- ARW 705.3K
- AXSM 655.3K
- Earning Date
- ARW 05-01-2025
- AXSM 05-05-2025
- Dividend Yield
- ARW N/A
- AXSM N/A
- EPS Growth
- ARW N/A
- AXSM N/A
- EPS
- ARW 7.28
- AXSM N/A
- Revenue
- ARW $27,813,081,000.00
- AXSM $432,157,000.00
- Revenue This Year
- ARW $0.02
- AXSM $63.52
- Revenue Next Year
- ARW $8.06
- AXSM $63.32
- P/E Ratio
- ARW $16.28
- AXSM N/A
- Revenue Growth
- ARW N/A
- AXSM 72.16
- 52 Week Low
- ARW $86.50
- AXSM $64.11
- 52 Week High
- ARW $137.80
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- ARW 68.29
- AXSM 46.37
- Support Level
- ARW $114.45
- AXSM $103.15
- Resistance Level
- ARW $119.46
- AXSM $120.00
- Average True Range (ATR)
- ARW 2.92
- AXSM 3.51
- MACD
- ARW 0.98
- AXSM 0.66
- Stochastic Oscillator
- ARW 91.32
- AXSM 29.45
About ARW Arrow Electronics Inc.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.